Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 15265819)

Published in Clin Chem on July 20, 2004

Authors

Minna Ala-Kopsala1, Jarkko Magga, Keijo Peuhkurinen, Jaana Leipälä, Heikki Ruskoaho, Juhani Leppäluoto, Olli Vuolteenaho

Author Affiliations

1: Department of Physiology, Biocenter Oulu, University of Oulu, Finland.

Articles citing this

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A (2005) 1.85

Biomarkers in acute myocardial infarction. BMC Med (2010) 1.22

Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease. Circulation (2011) 1.01

Effect of sialylated O-glycans in pro-brain natriuretic peptide stability. Clin Chem (2010) 0.93

NT-ProBNP levels in saliva and its clinical relevance to heart failure. PLoS One (2012) 0.84

Intermittent levosimendan treatment in patients with severe congestive heart failure. Clin Res Cardiol (2013) 0.83

Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension. Am J Hypertens (2009) 0.82

The association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohort. PLoS One (2011) 0.82

N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations. Clin Res Cardiol (2011) 0.82

Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension. Am J Cardiol (2009) 0.80

Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study. PLoS One (2014) 0.79

Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction. Clin Res Cardiol (2010) 0.78

Natriuretic peptides as biomarkers in heart failure. J Investig Med (2013) 0.77

Circulating N-terminal brain natriuretic peptide and cardiac function in response to acute systemic hypoxia in healthy humans. J Transl Med (2014) 0.77

The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25). Diabetes Care (2012) 0.77

Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli. Microb Cell Fact (2016) 0.76

Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarction: study protocol for a randomized controlled trial. Trials (2014) 0.75

Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol (2017) 0.75

Articles by these authors

Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation (2003) 2.48

GATA transcription factors in the developing and adult heart. Cardiovasc Res (2004) 2.30

Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res (2002) 2.15

A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens (2003) 1.96

Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart. Circ Res (2006) 1.92

Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J (2006) 1.80

Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol (2004) 1.80

A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy. Eur Heart J (2004) 1.78

Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology (2002) 1.74

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J (2015) 1.68

Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension (2005) 1.57

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart (2012) 1.54

Genetics of dilated cardiomyopathy. Ann Med (2007) 1.52

Characterization of molecular forms of N-terminal B-type natriuretic peptide in vitro. Clin Chem (2010) 1.41

Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J (2007) 1.24

Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women. Osteoporos Int (2004) 1.23

Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun (2003) 1.19

Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy. Heart (2009) 1.15

Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heart. J Biol Chem (2004) 1.15

Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression. J Physiol (2003) 1.12

The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. Endocrinology (2005) 1.11

Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy. Circ Res (2010) 1.09

B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up. Ann Med (2010) 1.09

Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J (2007) 1.09

The effect of birth in secondary- or tertiary-level hospitals in Finland on mortality in very preterm infants: a birth-register study. Pediatrics (2007) 1.07

GATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic program. J Biol Chem (2003) 1.07

Effect of impact exercise and its intensity on bone geometry at weight-bearing tibia and femur. Bone (2006) 1.07

Thrombospondin-4 expression is rapidly upregulated by cardiac overload. Biochem Biophys Res Commun (2008) 1.06

Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J (2010) 1.06

Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy. Eur J Heart Fail (2004) 1.03

Evaluation of methods for assessment of pain associated with chronic osteoarthritis in dogs. J Am Vet Med Assoc (2003) 1.03

Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons. Neuroendocrinology (2008) 1.03

Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis. Circulation (2007) 1.02

Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord (2002) 1.01

Evaluation of the perioperative stress response in dogs administered medetomidine or acepromazine as part of the preanesthetic medication. Am J Vet Res (2002) 1.00

MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease. Ann Med (2015) 1.00

Impact of very preterm birth on health care costs at five years of age. Pediatrics (2010) 0.99

The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res (2009) 0.99

Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Int J Cardiol (2007) 0.99

p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms. FASEB J (2006) 0.98

Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men. Eur Heart J (2006) 0.98

Cold exposure and hormonal secretion: a review. Int J Circumpolar Health (2002) 0.97

Effect of daily physical activity on proximal femur. Clin Biomech (Bristol, Avon) (2005) 0.97

Calmodulin kinase modulates Ca2+ release in mouse skeletal muscle. J Physiol (2003) 0.96

Ultrasonographic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation (2002) 0.96

Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice. Endocrinology (2005) 0.96

Effect of repeated exposures to cold on cognitive performance in humans. Physiol Behav (2005) 0.95

GATA-4 is an angiogenic survival factor of the infarcted heart. Circ Heart Fail (2010) 0.95

Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study. J Nucl Cardiol (2007) 0.95

Natriuretic peptides and hemodynamics in preeclampsia. Am J Obstet Gynecol (2007) 0.94

Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats. Cardiovasc Res (2010) 0.93

Effect of impact exercise on physical performance and cardiovascular risk factors. Med Sci Sports Exerc (2007) 0.93

Cardiac BNP gene activation by angiotensin II in vivo. Mol Cell Endocrinol (2007) 0.92

A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy. J Mol Med (Berl) (2003) 0.92

Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene. J Biol Chem (2002) 0.92

BNP as a biomarker in heart disease. Adv Clin Chem (2005) 0.92

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy. J Cardiovasc Magn Reson (2011) 0.91

Neuronostatin, a novel peptide encoded by somatostatin gene, regulates cardiac contractile function and cardiomyocyte survival. J Biol Chem (2011) 0.91

Regular physical exercise, heart rate variability and turbulence in a 6-year randomized controlled trial in middle-aged men: the DNASCO study. Life Sci (2005) 0.91

Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation. Eur Radiol (2011) 0.91

Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure. Int J Cardiol (2012) 0.90

Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Hypertension (2014) 0.90

Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways. Pflugers Arch (2001) 0.90

Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency. Nephrol Dial Transplant (2011) 0.90

Thrombospondins, potential drug targets for cardiovascular diseases. Basic Clin Pharmacol Toxicol (2013) 0.89

Effects of repeated whole-body cold exposures on serum concentrations of growth hormone, thyrotropin, prolactin and thyroid hormones in healthy women. Cryobiology (2009) 0.89

Seasonal changes in thermal responses of urban residents to cold exposure. Comp Biochem Physiol A Mol Integr Physiol (2004) 0.89

Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides. Endocrinology (2007) 0.89

Posttranscriptional control of BNP gene expression in angiotensin II-induced hypertension. Hypertension (2002) 0.88

Increased fetal cardiac natriuretic peptide secretion in type-1 diabetic pregnancies. Acta Obstet Gynecol Scand (2008) 0.87

Urinary melatonin: a noninvasive method to follow human pineal function as studied in three experimental conditions. J Pineal Res (2006) 0.87

Health-related quality of life in 5-year-old very low birth weight infants. J Pediatr (2009) 0.87

First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene. Radiology (2003) 0.87

Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. J Card Fail (2008) 0.86

Cardiac hypertrophy and altered hemodynamic adaptation in growth-restricted preterm infants. Pediatr Res (2003) 0.86

Metoprolol versus amiodarone in the prevention of atrial fibrillation after cardiac surgery: a randomized trial. Ann Intern Med (2010) 0.86

Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol (2004) 0.86

BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells. Tumour Biol (2011) 0.86

Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility. Circulation (2008) 0.86

The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissues. Life Sci (2005) 0.86

Role of reactive oxygen species in the regulation of cardiac contractility. J Mol Cell Cardiol (2011) 0.86

Upregulation of cardiac matrix Gla protein expression in response to hypertrophic stimuli. Blood Press (2009) 0.85

Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms. Circ Heart Fail (2011) 0.85